Fosaprepitant
NDC 31722-165, Fosaprepitant dimeglumine, injection, powder, lyophilized, for solution, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-165
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214616
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FOSAPREPITANT DIMEGLUMINE150 mg/5mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-165-31 | 31722016531 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7dbdf8f5-6936-4143-b52d-96774b799a7d
Use it
Look up 31722-165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.